1-(2-Mesitylene)-1,3-butanedione>96.0%(GC)25g

Oxyde de manganèse(IV) en poudre 99,9% 50 g

2-(4-methylphenyl)-1H-indene-1,3(2H)-dione, 95.0%, 1g

2-Amino-5-chloro-3-methylpyridine>98.0%(GC)(T)5g

3-(5-Oxo-1-phenyl-2-thioxoimidazolidin-4-yl)propanoic acid, 95%, 100mg

4-Bromo-7-fluoro-1H-pyrrolo[3,2-c]pyridine, 97%, 250mg

Colonne capillaire GC ROTI®Cap-5, 30 m, 0,25 mm, 0,35 µm, 1 pièce(s)

Methyl 2-(2-bromo-4-fluorophenyl)acetate, 99.0%, 1g

6-Bromo-2-(2-(3-methoxyphenyl)propan-2-yl)benzofuran-3-carboxylic acid, 97%, 100mg

2-Pyrrol-1-yl-benzoic acid hydrazide, 95.0%, 10g

4-[(2-Chloro-acetylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 25g

3-OXASPIRO[5.5]UNDECAN-9-ONE, 95.0%, 250mg